The next EACPT Congress will be held from 29th June to 2nd July in 2019
in Stockholm as a partnership between the EACPT and the Swedish Society for
Pharmacology, Clinical Pharmacology and Therapeutics.
The Congress will address Tomorrow's Healthcare Challenges and will be
held at the City Conference Centre - 5 minutes from Stockholm Central Station.
The Congress Reception on the evening of Saturday 29th June, will be
held at Stockholm City Hall, the venue of the Nobel Prize banquet.
The Keynote Opening Lecture will be given by the President at the
Karolinska Institute, Professor Ole Petter Ottersen, on global health and
clinical pharmacology.
Professor Urs Meyer from Switzerland will give the 2019 EACPT Lifetime
Achievement Award Lecture based on his work on individual variation in drug
response.
Further awards will be presented, including Scientific Awards, including
Young Investigator, and EACPT Education Awards.
Around 60 invited speakers are expected from throughout Europe and
beyond. Congress keynote lectures will include:
Plenary lectures
Ylva Böttiger: Clinical
pharmacology reaching out - 25 years with EACPT
Ole Petter Ottersen: Global
health research and education in Europe - how can clinical pharmacology
contribute?
Harry Sokol: Gut microbiota - a
new actor in pharmacology?
Urs Meyer: Therapeutic Lessons
from Human Individuality
Rosa Giuliani: Update on treating
breast cancer
Jenny Kindblom: Pediatric
clinical trials and their pitfalls
Tim Nicholson: New targets in
psychopharmacology
Sylvie Laporte:
Meta-epidemiological studies to detect, quantify and adjust for bias in
open-label trials
Stefan James: Innovative ways of performing
clinical trials
Björn Wettermark: How to measure
drug utilisation
Cardiovascular prevention
Stephane Laurent: Update on
treating hypertension
Gerard Rongen: PCSK9 inhibitors -
going lower but for whom and at what price? Paul Hjemdahl: Dual or triple antithrombotic therapy - is
two company and three a crowd?
An ageing population
Denis O'Mahoney: STOPP/START
decision support for elderly prescribing
Anne Spinewine: Prescribing in
the frail elderly
Workshops
Martin Henriksson: How to perform
a health economic study
Olof Beck and Markus Meyer: How to measure drug exposure
Jan Marcusson: How to make on
oral presentation and feel good about it
Closing the money gap
Gerd Lärfars: Horizon scanning
frontiers
Andras Inotai: How to solve money
gap to ensure patient access to pharmaceuticals in EU counties
David Webb: Health economics: big
ideas from a small country
Personalized medicine : joint
EACPT-EPHAR session
Henk Jan Guchelaar: Clinical
implementation of pharmacogenetics
Viktor Hlavac: Pharmacogenetics
of cancer chemoresistance
Seppo Ylä-Herttuala:
Cardiovascular gene therapy
Martina Schusler-Lenz: Advanced
therapy regulation in the EU
Interprofessional working
Ann Lykkegaard Sørensen:
Interprofessional approach for safer medication in psychiatry
Hanna Seidling: Benchmarks for
successful interdisciplinary collaboration
Debate: Deprescribing is Dangerous
Jamie Coleman: For; Wade Thompson : Against
Targeting small populations
Caridad Pontes: barriers to market access,
Violeta Stoyanova: drug designation and other regulatory
challenges
Critically ill patients
Dario Cattaneo: Anti-infectives
in intensive care
Philippe Vignon: New sepsis drugs
in the pipeline: any reason for hope?
Christoph Stein: New concepts in
opioid analgesia
Antibiotic drug resistance
Johan Mouton: Antimicrobial
resistance. Could PK/PD be the answer?
Alexandra Aubry: New treatment
options for resistent tuberculosis
Polypharmacy: joint session with the
Korean Society
Howard Lee: Polypharmacy in Korea
Ho Sook Kim: The clinical
pharmacology perspectives for the optimal polypharmacy in Korea
Kees Kramers: Polypharmacy:
Acting on the cutting edge of safety, efficacy and compliance
Patient empowerment
Bettina Ryll: Patient empowerment:
Issues with introduction of a new class of drugs
Ann Langius Eklöf: Smart phones
provide smart patients
2020 drug strategy
Jordi Llinares: achievements and future initiatives; Drug
regulation in the 2020s: Gonzalo Calvo:
an academic perspective; Graziella Collu: a pharmaceutical industry perspective
Decision support
Matthew Doogue: Alert, clinical
decision support helping patients and hindering work flow
Lars L Gustafsson: Clinical
pharmacologists with computers - the way forward
